MEI Pharma

-$0.06 (-2.17%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MEI Pharma and other ETFs, options, and stocks.

About MEIP

MEI Pharma, Inc. is a pharmaceutical company, which engages in the clinical development of therapies for cancer. Its drug candidates include Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome.

CEO
Daniel P. Gold
Employees
51
Headquarters
San Diego, California
Founded
2000

MEIP Key Statistics

Market Cap
343.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
523.12K
High Today
$2.81
Low Today
$2.66
Open Price
$2.76
Volume
553.77K
52 Week High
$4.58
52 Week Low
$2.29

MEIP Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Sep 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure